Spe2d220r0063 Bupropion Xl Amendment 0002 Tender

Notice for Spe2d220r0063 Bupropion Xl Amendment 0002 in USA. The reference ID of the tender is 45500487 and it is closing on 01 Sep 2025.

Tender Details

Country: USA
Summary: Spe2d220r0063 Bupropion Xl Amendment 0002
UST Ref No: 45500487
Deadline: 01 Sep 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: SPE2D220R00630002
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Spe2d220r0063 Bupropion Xl Amendment 0002
Active Contract Opportunity
Notice ID : SPE2D220R00630002
Related Notice : SPE2D220R0063
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE LOGISTICS AGENCY (DLA)
Major Command : TROOP SUPPORT MEDICAL
Office : DLA TROOP SUPPORT
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Sep 03, 2020 04:04 pm EDT
Original Response Date: Sep 01, 2025 03:00 pm EDT
Inactive Policy: Manual
Original Inactive Date: Sep 01, 2025
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance:
Description
AMENDMENT 0002 TO SOLICITATION INCORPORATING TELECOMMUNICATION CLAUSES. SOLICITATION IS NOT REOPENED. CLOSING DATE IS NOT EXTENDED.
Documents:

Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Spe2d220r0063 Bupropion Xl Amendment 0002 - USA Tender

The DEPT OF DEFENSE, a Government sector organization in USA, has announced a new tender for Spe2d220r0063 Bupropion Xl Amendment 0002. This tender is published on USARFP under UST Ref No: 45500487 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-01.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

Tenders Category

Construction and Real Estate

Energy and Related Services

IT & Softwares

All Categories

Create New Account

USARFP Features

Fresh and verified Tenders from USA. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

1,000+ Tenders
Verified Tenders Only
New Tenders Every Day
Tenders Result Data
Archive & Historical Tenders Access
Consultants for RFI/RFP/RFQ
Tender Notifications & Alerts

Search, Sort, and Filter Tenders
Bidding Assistance & Consulting
Customer Support
Publish your Tenders
Export data to Excel
API for Tender Data
Tender Documents

Get Daily Tender Alerts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting USARFP !!

Email Id is already exist !!

Get FREE SAMPLE TENDERS from USA in your email inbox.